{"abstract":"The Food and Drug Administration (FDA) is announcing a public meeting to discuss the proposed recommendations for a user fee program for biosimilar biological products for fiscal years (FYs) 2013 through 2017.","action":"Notice of public meeting; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2011/12/07/2011-31499.html","cfr_references":[],"citation":"76 FR 76424","comment_url":null,"comments_close_on":"2012-01-06","correction_of":null,"corrections":[],"dates":"The public meeting will be held on Friday, December 16, 2011, from 9 a.m. to 1 p.m. Registration to attend the meeting must be received by December 14, 2011. See section III.B of this document for information on how to register for the meeting. Submit either electronic or written comments by January 6, 2012.","disposition_notes":null,"docket_ids":["Docket No. FDA-2011-N-0326"],"dockets":[],"document_number":"2011-31499","effective_on":null,"end_page":76429,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2011/12/07/2011-31499.xml","html_url":"https://www.federalregister.gov/documents/2011/12/07/2011-31499/biologics-price-competition-and-innovation-act-of-2009-proposed-recommendations-for-a-user-fee","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2011-31499?publication_date=2011-12-07","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2011-12-07/2011-31499/mods.xml","not_received_for_publication":null,"page_length":6,"page_views":{"count":1236,"last_updated":"2026-09-22 18:15:08 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2011-12-07/pdf/2011-31499.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2011-31499.pdf?1323119832","publication_date":"2011-12-07","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2011/12/07/2011-31499.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2011-12-07T16:00:14Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":76424,"subtype":null,"title":"Biologics Price Competition and Innovation Act of 2009; Proposed Recommendations for a User Fee Program for Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 Through 2017; Notice of Public Meeting; Request for Comments","toc_doc":"Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 Through 2017; Meeting","toc_subject":"Recommendations for User Fee Programs:","topics":[],"type":"Notice","volume":76}